Poster highlighting proof-of-concept study of Citius’ iPSC-derived stem cell therapy in acute lung injury chosen for Best Poster Award at ISCT 2021 from among 336 posters selected from,400 abstracts submitted […]
Newly Issued Claims Extend Patent Protection to Year 2039 for Nyxol®Combination Therapy for Presbyopia […]
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. […]
Interview with Christos Doulis, CEO
[…]
Vancouver, British Columbia–(Newsfile Corp. – May 18, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced it […]
Revenue up 34% and EPS up 4,391% to all-time record EPS of $0.002 and first profitable quarter in the Company’s most recent history […]
Launch of Psychedelics DNA Test Kit,
Phase 1 clinical trial for DMT progressing as planned,
Pre-clinical In Vivo work scheduled to start at Israeli CRO […]
May 17th at 10:15 AM ET […]
All drill holes cut a wide interval (up to 90 meters overall in hole 11) containing zones of quartz carbonate veining with strong albite-sericite-silica alteration halos. […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com
